Special Issue "Biomedicines from Marine Invertebrate-Microbial Symbioses"

Guest Editor
Dr. Paul Long
Institute of Pharmaceutical Science & Department of Chemistry, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
E-Mail: paul.long@kcl.ac.uk
Interests: biochemical adaptations; streptomyces genetics; natural products discovery; bioinformatics

Submission

All papers should be submitted to marinedrugs@mdpi.com with copy to the Editors. To be published continuously until the deadline and papers will be listed together at the special websites. Both, research articles and review articles are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editors for announcment on this website.

Submitted papers should not have been published previously, nor be under consideration for publication elsewhere. All papers are refereed through a peer-review process. A guide for authors, sample copies and other relevant information for submitting papers are available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a paper. Open Access publication fees are 1000 CHF per paper. English correction fees (250 CHF) will be added in certain cases (1250 CHF per paper for those papers that require extensive additional formatting and/or English corrections.).

• biomedicines
• marine drugs
• marine invertebrate-microbial symbioses